FDA is committed to protecting national health and security. We are working to foster the development and availability of medical products that will be needed to counter a public health emergency, no matter its origin.
The FDA Medical Countermeasures Initiative (MCMi) mission has three main components:
Public Health and Security Action Teams promote the development and availability of medical countermeasures (MCMs) by establishing clear regulatory pathways A robust MCM regulatory science program creates the data necessary to support regulatory decision-making A collaborative effort to modernize the legal, regulatory and policy framework establishes effective policies and mechanisms to facilitate timely access to available MCMs
Sign up to receive email alerts on emergency preparedness and response topics from FDA, including medical countermeasures and emerging infectious diseases.